Psoriatic arthritis therapy ‘Guselkumab’ acquires approval in Korea

Published: 2018-04-18 16:26:00
Updated: 2018-04-18 18:29:55

‘Guselkumab(product name: Tremfya Prefilled Syringe Inj),’ a Janssen’s psoriasis & arthritis therapy, acquired approval in Korea.

The Ministry of Food and Drug Safety(MFDS) decided new drug approval on ‘Tremfya Prefilled Syringe Inj(generic name: guselkumab),’ a Janssen Korea’s psoriasis & arthr...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.